Alkermes (ALKS) Payables (2011 - 2026)
Alkermes (ALKS) reported Payables of $102.4 million for Q1 2026, down 44.98% year-over-year from $186.0 million in Q1 2025, and down 64.65% quarter-over-quarter from $289.6 million in Q4 2025.
Alkermes (ALKS) Payables (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Payables data on file, last reported at $102.4 million in Q1 2026.
- Payables for Q1 2026 came in at $102.4 million, down 44.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $102.4 million (down 44.98% YoY), and the FY2025 annual result was $289.6 million, up 56.24% from the prior year.
- Payables retreated to $102.4 million in Q1 2026 per ALKS's latest filing, from $289.6 million in the prior quarter.
- Over five years, Payables peaked at $289.6 million in Q4 2025 and troughed at $33.2 million in Q3 2022.
- A 5-year average of $172.4 million and a median of $186.8 million in 2022 frame the typical range for Payables.
- The sharpest annual moves came in 2023 and 2024: Payables jumped 632.74% in 2023, then tumbled 84.77% in 2024.
- A 5-year view of Payables shows it stood at $220.1 million in 2022, then rose by 9.3% to $240.6 million in 2023, then declined by 22.96% to $185.3 million in 2024, then surged by 56.24% to $289.6 million in 2025, then tumbled by 64.65% to $102.4 million in 2026.
- Business Quant data shows ALKS's Payables at $102.4 million in Q1 2026, $289.6 million in Q4 2025, and $68.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 731.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 93.08 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 45.88 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 306.87 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 10.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.36 Mn |
| Dec 31, 2025 | 289.57 Mn |
| Sep 30, 2025 | 68.00 Mn |
| Jun 30, 2025 | 245.75 Mn |
| Mar 31, 2025 | 186.04 Mn |
| Dec 31, 2024 | 185.33 Mn |
| Sep 30, 2024 | 37.04 Mn |
| Jun 30, 2024 | 239.77 Mn |
| Mar 31, 2024 | 205.85 Mn |
| Dec 31, 2023 | 240.56 Mn |
| Sep 30, 2023 | 243.26 Mn |
| Jun 30, 2023 | 84.62 Mn |
| Mar 31, 2023 | 190.15 Mn |
| Dec 31, 2022 | 220.09 Mn |
| Sep 30, 2022 | 33.20 Mn |
| Jun 30, 2022 | 186.81 Mn |
| Mar 31, 2022 | 173.13 Mn |
| Dec 31, 2021 | 208.49 Mn |
| Sep 30, 2021 | 36.88 Mn |
| Jun 30, 2021 | 32.80 Mn |